Quick Answer
CORCEPT THERAPEUTICS INC reported Long Term Debt of $0.00 for the year ending 2016.
- CORCEPT THERAPEUTICS INC showed a decrease of -100.0% in Long Term Debt from 2015 to 2016.
- This data is from CORCEPT THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 6, 2017.
- XBRL data for this metric is available from 2012 to 2016 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $28.33 million | Q1 2013: $28.90 million | Q2 2013: $30.24 million | Q3 2013: $30.14 million | Q1 2014: $28.22 million | Q2 2014: $27.64 million | Q3 2014: $25.99 million | Q1 2015: $22.13 million | Q2 2015: $19.40 million | Q3 2015: $16.13 million | Q1 2016: $8.72 million | Q2 2016: $3.74 million | Q3 2016: $0.00.
- Over the full 5 years of available data (2012 to 2016), CORCEPT THERAPEUTICS INC's Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2016: $0.00 | Fiscal year 2015: $12.53 million | Fiscal year 2014: $24.46 million | Fiscal year 2013: $29.32 million | Fiscal year 2012: $29.03 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: